Methotrexate vs Osimertinib
Methotrexate vs Osimertinib: Overview
This comparison examines the pharmacological differences between Methotrexate and Osimertinib.
Mechanism of Action
Methotrexate: Dihydrofolate reductase inhibitor.
Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.
Pharmacokinetics
Half-life: Methotrexate — 3-10 hours; Osimertinib — 48 hours.
Chemical Properties
Molecular Formula: Methotrexate — C20H22N8O5; Osimertinib — C28H33N7O2.
Molecular Weight: Methotrexate — 454.4400 g/mol; Osimertinib — 499.6050 g/mol.
Type: Methotrexate — Small molecule; Osimertinib — Small molecule.